EKB Journal Management System


51.	Long-term Follow-up of Chronic Hepatitis C Patients Treated by Direct- Acting Antivirals
	Volume 90, Issue 2, January 2023, Pages 2767-2774
	Ahmed Tawheed; Mohamed El-Kassas; Amr El-Fouly; Gamal Esmat
	View Article PDF 269.24 K

52.	Accuracy of Rapid Serological Test versus Reference Standard Test for Hepatitis C Virus among Blood Donors
	Volume 10, Issue 1, January 2023, Pages 239-250
	Nada Ibrahim Zayed; Samia Abd-Elmoaty; Samar Abdelraoof
	View Article PDF 676.47 K

53.	Relation between Psoriasis Severity and P53 Apoptosis Marker in HCV Infection in Mansoura
	Volume 57, Issue 4, December 2022, Pages 1-7
	Fathy E. E. Khalil; Heba E. A. El Degla; Ahmed F. State; Abdel-Fattah, G.M
	View Article PDF 1.16 M

54.	Hepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression
	Volume 65, Issue 132, December 2022, Pages 1437-1447
	Abeer Mohamed Abd El-Hameed
	View Article PDF 782.21 K

55.	Incidence of hepatitis B and C viruses among the scavengers in Kwara State, Nigeria
	Volume 3, Issue 4, November 2022, Pages 899-909
	Morufu Olalekan Raimi; Yusuf Olanrewaju Raufu; Adewoye Solomon Olayinka; Morufu Olalekan Raimi
	View Article PDF 542.47 K

56.	Interleukin-18 as a Promising Noninvasive Marker for Esophageal Varices: Correlation to Hepatic Dysfunction
	Volume 28, Issue 6.2, November 2022, Pages 374-385
	Mahmoud Ahmed Sharafeddin; Doaa M. AbdElmonem; Fady M. Wadea; shady E. shaker
	View Article PDF 624.33 K

57.	Comparing The Efficacy and Safety of (Ombitasvir/ Paritaprevir/ Ritonavir) in Management of Chronic HCV Patients Among Haemodialysis Patients and Those with Normal Renal Functions
	Volume 89, Issue 2, October 2022, Pages 6889-6894
	Alaa Ahmed Mahmoud; Hussein El Ameen; Nashwa Mostafa
	View Article PDF 436.09 K

58.	A Survey Study: Nurses' Knowledge and Attitudes regarding Hepatitis C Virus
	Volume 10, Issue 32, September 2022, Pages 1-10
	Feryal Rashad Mahmoud; shalabia El-sayed abozead; Ghada Hassan Ahmed
	View Article PDF 974.04 K

59.	Exploring Effect of Medication Adherence on Quality of Life among Newly Treated Hepatitis “C” Virus Patients
	Volume 13, Issue 3, September 2022, Pages 1442-1452
	Thoraya Mohamed Abdelaziz; Laila A. Hamed; Nagwa Mohamed Helmy Emam
	View Article PDF 1.21 M

60.	Evaluation of the Potential role of MicroRNA 126 in Hepatitis C infection patients treatment Outcomes
	Volume 42, Issue 2, September 2022, Pages 19-24
	Dalia Mohamed Shaker Elkholy; Mohamed Mahfouz
	View Article PDF 1.29 M

61.	Serum Golgi protein 73 and glypican-3: early diagnostic biomarkers for hepatocellular carcinoma
	Volume 27, Issue 3, August 2022
	Doaa F. Gad; Islam Eid Mohamed; Essam Elmahdi; Abdelnaser A. Badawy; Gamal Othman; Mohamed G. Dawoud; Mohammed Diasty; Maysaa E. Zaki; Mohamed M. Abd El-Mawgod
	View Article PDF 259.97 K

62.	Response to Hepatitis B Vaccine in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals
	Volume 39, Issue 2, July and August 2022, Pages 346-356
	Said EM; Dalia Nour El Din; Mona Ahmed Elawady; Shaimaa Yehia Ragab; Tamer E El-Eraky
	View Article PDF 712.14 K

63.	HEPATITIS C VIRUS INFECTION RATES AMONG EGYPTIAN BLOOD DONORS AFTER IMPLEMENTATION OF THE NATIONAL TREATMENT PROGRAM
	Volume 51, Issue 3, July 2022, Pages 1679-1692
	Ahmed Mohamed Abd El-Wahed; Helmy Ahmed Shalaby; Mohamed Saad El-Deen Radwan; Ashraf Mohamed El-Bahrawy
	View Article PDF 365.99 K

64.	Role of Triphasic Computed Tomography for Detection of Hepatitis C Virus Consequences: Review Article
	Volume 88, Issue 1, July 2022, Pages 2535-2538
	Heba Fathy Tantawy; Stefany Adel AbdElMalak; Adel Mohamed Sanoor; Maha Ibrahim Metwally
	View Article PDF 359.53 K

65.	Comparative Study between Responders and Non Responders Among Patients Treated for Hepatitis C virus Infection
	Volume 39, Issue 2, July and August 2022, Pages 589-601
	Amr Elhammadi; Dina Ziada; Wael Farrag
	View Article PDF 486.84 K

66.	A real-life experience of dermatological manifestations associated with direct-acting antivirals for chronic hepatitis C virus infection
	Volume 7, Issue 3, July 2022, Pages 227-231
	Mohamed F. Alsayed; Nahed A. Makhlouf; Eman R.M. Hofny; Hanan M. Nafeh; Ahmad F.A. Hasanain; Mohamed A. El-Mokhtar; Helal F. Hetta; Nasr K. Khalil; Mohamed A. Mekky; Mohamed Alboraie; Ahmed M. Nasr; Hussein Elamin
	View Article PDF 1.34 M

67.	Association between Epidermal Growth Factor ‎‎+61A/G (rs4444903) Gene Polymorphism with ‎Risk of Hepatocellular Carcinoma in Cirrhotic ‎Hepatitis C Patients
	Volume 12, Issue 2, June 2022, Pages 106-114
	Ayman F El Shayeb; Sara Asser; Nehal E Bahnasy; Doaa A Elwazzan
	View Article PDF 301.6 K

68.	Assessment of Haematological and Immunological Effect after New Direct ‎Acting Antiviral Drugs in Chronic Hepatitis C Virus Egyptian Patients
	Volume 12, Issue 2, June 2022, Pages 169-177
	Sahr E Hussein; Howaida A Nafady; Tarek A Hassan
	View Article PDF 358.51 K

69.	Nurses' Performance Regarding the Application of Preventive Measures of Hepatitis C virus Infection among Children Undergoing Hemodialysis
	Volume 13, Issue 2, June 2022, Pages 970-979
	Wafaa Ahmed Mohamed; Randa Mohamed Adly; Safaa Abdel Fattah AbouZed
	View Article PDF 0 K

70.	The Impact of Achieving Sustained Virological Response with Direct Acting Antivirals on Gastroesophageal Varices and Variceal Bleeding
	Volume 2022, Issue 5, May 2022, Pages 17-21
	Mohamed elsayed sarhan; Ahmed Atta Elhadidy; Mohamed M. Mabrouk; Ahmed Fawzy Selim
	View Article PDF 641.28 K

71.	Assessment of antisperm antibodies in patients with hepatitis C virus infection : A controlled study
	Volume 12, Issue 12, April 2022, Pages 1-6
	Rashad Mahmoud Mostafa; Nashaat Mohamed Soliman; Nourhan elsebaey mohamed; hany Mohammed Saad
	View Article PDF 737.11 K

72.	Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study
	Volume 6.2, Issue 2, April 2022, Pages 11-17
	Muhammad Diasty; Khaled Taha; Ayman Elgamal; Maha Ibrahem; Ola El-Emam; Kamal salama; Essam Elmahdi
	View Article PDF 229.03 K

73.	Genetic Polymorphisms of Monocyte Chemotactic Protein-1 and Risk of Spontaneous Bacterial Peritonitis in Post Hepatitis C Cirrhotic Patients
	Volume 87, Issue 1, April 2022, Pages 1517-1522
	Rashed Mohammed Hassen; Sahar Abdelshafy Elnemr; Heba Fouad Pasha; Akram Said Ali Khafagy; Ahmed S. Mohammed
	View Article PDF 378.53 K

74.	Safety and Efficacy of Direct Acting Antivirals for Hepatitis C Virus Infection in Thalassemic Patients and Its Effect on Transfusion Requirements
	Volume 87, Issue 1, April 2022, Pages 1975-1981
	Gina Gamal Naguib; Maha Abd El-Aziz Eltouny; Ossama Ashraf Ahmed; Iman Ahmed Ragab; Shereen Abdel-Monem Ibrahim; Sherif Ahmed Megahed Ahmed; Walaa M. Hashem
	View Article PDF 393.28 K

75.	Non-invasive Evaluation of Liver Fibrosis Changes in Patients with Chronic ‎Hepatitis C after Directly Acting Antiviral Drugs
	Volume 12, Issue 1, March 2022, Pages 92-98
	Taha M Hassanin; Hala Ibraheem; Madeha Makhlouf; Waleed Mahmoud; Nadia El-Ameen; Enas Kamal
	View Article PDF 317.66 K
Records Per Page 1 2 3 4 5 6 7 8